We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

An Extension Protocol for Virologically Suppressed Subjects Who Successfully Completed PRO140_CD03 Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT05271370
Recruitment Status : Active, not recruiting
First Posted : March 9, 2022
Last Update Posted : March 9, 2022
Information provided by (Responsible Party):
CytoDyn, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 20, 2022
Estimated Study Completion Date : April 10, 2023